Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
RLH Equity Partners (Riordan, Lewis & Haden) is a leading private equity firm that specializes in investing in high-growth, lower middle-market enterprises. The firm focuses on three primary sectors: healthcare, business services, and government services. Within the healthcare and life sciences space, RLH targets tech-enabled services, clinical research organizations (CROs), and specialized healthcare consulting firms that support the pharmaceutical and biotechnology industries. The firm typically partners with management teams to provide strategic guidance and capital to help companies scale their operations and enhance market positioning. Notable past and present investments in the life sciences sector include ClearView Healthcare Partners and The CM Group.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Riordan, Lewis & Haden.